Dr. Burant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24 Frank Lloyd Wright Dr
Lobby C Suite 1300
Ann Arbor, MI 48105Phone+1 734-998-2450Fax+1 734-647-5865
Education & Training
- University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
- University of California (San Francisco)Internship, Internal Medicine, 1987 - 1988
- Medical University of South CarolinaClass of 1987
Certifications & Licensure
- MI State Medical License 1998 - 2026
- IL State Medical License 1989 - 1999
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy Start of enrollment: 2012 Oct 08
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance Start of enrollment: 2009 Aug 01
- Endogenous Opioid Activity and Affective State in Insulin Resistant Women Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Impaired suppression of fatty acid release by insulin is a strong predictor of reduced whole-body insulin-mediated glucose uptake and skeletal muscle insulin receptor ...Michael W Schleh, Benjamin J Ryan, Cheehoon Ahn, Alison C Ludzki, Douglas W Van Pelt
Acta Physiologica. 2024-11-01 - Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss.Jordan Wean, Salisha Baranwal, Nicole Miller, Jae Hoon Shin, Robert W O'Rourke
Diabetes & Metabolism. 2024-09-01 - 1 citationsIntestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance.Nadejda Bozadjieva-Kramer, Jae Hoon Shin, Ziru Li, Alan C Rupp, Nicole Miller
JCI Insight. 2024-04-08
Press Mentions
- New Taubman Scholars AppointedJuly 22nd, 2021
- Admitting Defeat in the Fight Against Obesity - the Medical Care BlogMarch 29th, 2021
- Fasting Plasma Metabolomic Profiles Are Altered by Three Days of Standardized Diet and Restricted Physical ActivityFebruary 6th, 2021
- Join now to see all
Grant Support
- Biology Of Aerobic Capacity And Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
- Tissue-Specific Metabolic Reprogramming In Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Nutrition And Obesity Research CentersNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Using Systems Biology To Understand Islet Adaptation And Failure DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Insulin Resistance And Hepatic Steatosis In Hepatitis CNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2010
- Michigan Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Insulin Sensitivity And Hepatic Steatosis In Hepatitis CNational Center For Research Resources2006–2007
- Metabolism &Gene Expression Patterns Of Muscle Satellite CellsNational Center For Research Resources2004–2006
- Identification Of Glucose Transporter Functional DomainsNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: